vimarsana.com

Page 103 - ஆரோக்கியம் பராமரிப்பு ஆம்ப் மருத்துவமனைகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Vireo Health and Former Executive Chairman Enter into Mutual Release

Vireo Health and Former Executive Chairman Enter into Mutual Release News provided by Share this article Share this article MINNEAPOLIS, March 31, 2021 /PRNewswire/ Vireo Health International Inc. ( Vireo or the Company ) (CNSX: VREO;OTCQX: VREOF), a leading physician-led, science-focused, multi-state cannabis company, today announced that it has entered into a mutual release (the Mutual Release ) with Bruce Linton, a globally recognized authority in cannabinoid policy and business and the Company s former Executive Chairman, relating to all outstanding matters between them. Mr. Linton joined Vireo in November of 2019. On June 8, 2020, the Company elected to terminate its employment agreement with Mr. Linton as Executive Chairman, on an entirely without-cause basis. In connection with Mr. Linton s employment agreement, Mr. Linton received warrants (the

CKGSB Economist Develops Dynamic Model for Reopening Strategies amid COVID-19

Share this article Share this article BEIJING, April 1, 2021 /PRNewswire/ With the COVID-19 vaccine being rolled out, many local and national governments are assessing how to safely reopen their economies while curtailing the number of positive cases. Professor of Economics, Zhong Ling, at the Cheung Kong Graduate School of Business (CKGSB) has developed a model framework which takes into account multiple epicenters that allows policymakers to simulate outcomes and guide reopening strategies. The model could offer policymakers the tools to quantitatively assess reopening policies prior to implementation. Dr. Zhong s research paper, A Dynamic Pandemic Model Evaluating Reopening Strategies amid COVID-19, was published in The Public Library of Science ONE (PLOS ONE).

Lifesum Continues Rapid Growth, Empowers Users to Take Control of Their Health From Home During Pandemic

Lifesum Continues Rapid Growth, Empowers Users to Take Control of Their Health From Home During Pandemic Lifesum Soars Past 50 Million Global Users and Introduces Inaugural Health Advisory Board News provided by Share this article LOS ANGELES, April 1, 2021 /PRNewswire/ Lifesum, the world s leading digital nutrition company, today announced its popular mobile app now has more than 50 million registered users. Spanning 250 countries and engaging in 11 different languages, Lifesum app users receive personalized nutritional guidance based on their individual goals and lifestyle. Lifesum strives to provide quality, expert-backed recommendations for people to become healthier through better food choices. As such, the company also today announced its Health Advisory Board. Tasked with helping the company remain innovative while providing additional expertise in fields impacting nutritional success, the Health Advisory Board will evolve along with the needs of Lifesum s user base.

Coronavirus (COVID-19) Update: FDA Continues to Advance Over-the Counter and Other Screening Test Development

Share this article Share this article SILVER SPRING, Md., March 31, 2021 /PRNewswire/ Following recent U.S. Food and Drug Administration actions to support test development, the FDA took swift action this week to get more tests for screening asymptomatic individuals on the market. Today, the agency authorized several tests for over-the-counter (OTC) use without a prescription when used for serial screening. In addition to the tests authorized for OTC use, one serial screening test was authorized for use in a point-of-care (POC) setting without a prescription, and an additional screening test was authorized for POC use with a prescription. The addition of the OTC and POC tests for screening will give schools, workplaces, communities and others several options for serial screening tests that are accurate and reliable. These authorizations follow the FDA s recent actions to advance OTC and other screening test development.

DefenAge Upgrades Its Core Skincare Trio and Launches It as a Mother s Day Special

DefenAge Upgrades Its Core Skincare Trio and Launches It as a Mother s Day Special Longer-lasting medical-grade skincare system now offers 50% more of the brand s iconic anti-aging serum. News provided by Share this article Share this article CARLSBAD, Calif., April 1, 2021 /PRNewswire/  DefenAge® Skincare, manufacturer and distributor of the revolutionary, evidence-based, anti-aging products, announces the launch of its best-selling Clinical Power Trio in its first ever PLUS-edition, delivering a longer-lasting dose of DefenAge s most in-demand, iconic product: the 8-in-1 BioSerum. The line s powerful and clinically proven core regimen now contains a MEGA size 8-in-1 BioSerum with 50 percent more than the standard size; the name on the upgraded trio is

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.